FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

412631008: Tau protein (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2468083018 Tau protein (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2474191017 Tau protein en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2478405017 Microtubule protein tau en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2478406016 Microtubule associated tau protein en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2478407013 Tau factor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tau protein (substance) Is a Protein true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Cerebrospinal fluid Tau protein measurement (procedure) Component False Tau protein (substance) Inferred relationship Some 2
Fluid sample Tau protein measurement (procedure) Component False Tau protein (substance) Inferred relationship Some 2
Tau protein, phosphorylated 181 Is a True Tau protein (substance) Inferred relationship Some
A rare late-onset neurodegenerative disease with characteristics of supranuclear gaze palsy, postural instability, progressive rigidity, and mild dementia. Five clinical variants have been described with clinicopathological correlations, with Richardson's syndrome the most common clinical variant. The disease has neuropathological manifestations of neuronal loss, gliosis with astrocytic plaques and accumulation of tau-immunoreactive neurofibrillary tangles in specific brain areas. The differences in the rate and areas of accumulation of phosphorylated tau protein correlate with the five clinical variants. The disease is a 4R tauopathy composed of a preponderance of four-repeat (exon 10 positive) tau isoforms and a characteristic biochemical profile (doublet tau 64 and tau 69). The MAPT H1-clade specific sub-haplotype, H1c, is a risk factor for this disease. Causative agent True Tau protein (substance) Inferred relationship Some 1
Atypical progressive supranuclear palsy syndrome Causative agent True Tau protein (substance) Inferred relationship Some 1
Progressive supranuclear palsy corticobasal syndrome (disorder) Causative agent True Tau protein (substance) Inferred relationship Some 2
Progressive supranuclear palsy parkinsonism syndrome (disorder) Causative agent True Tau protein (substance) Inferred relationship Some 1
Progressive supranuclear palsy progressive non fluent aphasia Causative agent True Tau protein (substance) Inferred relationship Some 1
Fluid sample Tau protein measurement (procedure) Component True Tau protein (substance) Inferred relationship Some 1
Cerebrospinal fluid Tau protein measurement (procedure) Component True Tau protein (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start